I agree.  Has anyone tried to get it off formulary in there institution and how 
successful were you.
Margaret

________________________________

From: [EMAIL PROTECTED] on behalf of Raye Dillon
Sent: Fri 11/4/2005 10:33 AM
To: [EMAIL PROTECTED]
Subject: RE: [vascular] Phenergan protocol



with all the good alternatives out there why are we still using this
drug. and dont tell me cost please

>>> "Nicastro, Margaret" <[EMAIL PROTECTED]> 11/2/2005 11:34:38 PM
>>>
A few years ago we were having numerous problems with our ER giving
phenergan IV push sometimes via a saline lock and sometimes via the
lowest port of the IV fluids but  stopping the fluids while
administering the phenergan.  Needless to say we had a number of
patients complaining of pain, infiltrations occuring.  I would address
this with our med safety committee and our P & T committee.  I finally
made some headway when a patient in the ER who also was a hospital
employee, a nurse and also a diabetic had a phenergan infiltrate.  I did
not like the looks of her hand and called her primary care physician and
recommended she be referred to a plastic surgeon.  She had an appt with
the plastic surgeon who followed her weekly for quite some time.  He
felt she might need plastic surgery but she opted to wait it out and
continued with his treatment of vaseline gauze to the site and an
acewrap.  After over a year you can hardly see where the infiltrate was.
 She knows it was there !
 and sometimes is embarrassed to show her hand.   After this incident
which I took back to the med safety committee and P & T with pictures of
her hand we changed our policy to read Phenergan must be diluted in a
syringe with 10 ml NSS and given slow IV Push.  This has cut down on our
infiltrates and pain issues. 

Margaret M Nicastro, CRNI, OCN
Coorordinator IV Therapy/Oncology
Gettysburg Hospital
147 Gettys Street
Gettysburg, PA 17325
Phone:  717-337-4312
Fax:  717-337-4485


________________________________

From: [EMAIL PROTECTED] on behalf of Lynn Hadaway
Sent: Wed 11/2/2005 4:19 PM
To: [EMAIL PROTECTED]; [EMAIL PROTECTED]
Cc: John Cole
Subject: Re: [vascular] Phenergan protocol


Gahart's Intravenous Medication handbook calls for promethazine to be
administered thru the injection port of a free flowing infusion. Lynn

At 3:34 PM -0500 11/2/05, Beverly Moore wrote:

        Does anyone out there have a protocol or policy requiring that
Phenergan be given sidearm on compatible fluid?  Would you be willing to
share?  We are thinking about implementing this.

        

        Beverly Moore, RN, BSN, OCN

        IV Therapy

        Danville Regional Medical Center

       
        

       
<http://ads.smartgroups.com/adclick/cid=000000c0c79a99a500000000>


        If you want to share pictures, use the calendar, or start a
questionnaire
        visit http://www.smartgroups.com/groups/vascular
       

        To leave the group, email: [EMAIL PROTECTED]

       
        Report abuse
<http://www.smartgroups.com/text/abusereport.cfm?gid=797122&mid=21529>



        Content-Type: image/gif; name="image001.gif"
        Content-ID: <[EMAIL PROTECTED]>
        Content-Description: image001.gif
       
        The following document was sent as an embedded object but not
referenced by the email above:
        Attachment converted: G4 Laptop:image001 8.gif (GIFf/«IC»)
(000B3D8A)



--
Lynn Hadaway, M.Ed., RNC, CRNI
Lynn Hadaway Associates, Inc.
126 Main Street, PO Box 10
Milner, GA 30257
http://www.hadawayassociates.com
office 770-358-7861

CONFIDENTIALITY NOTICE: 

This email may contain confidential health information that is legally
privileged.  This information is intended for the use of the named
recipient(s). The authorized recipient of this information is prohibited
from disclosing this information to any party unless required to do so
by law or regulation and is required to destroy the information after
its stated need has been fulfilled.  If you are not the intended
recipient, you are hereby notified that any disclosure, copying,
distribution, or action taken in reliance on the contents of this email
is strictly prohibited.  If you receive this e-mail message in error,
please notify the sender immediately to arrange disposition of the
information.









Reply via email to